Sabra Health Care REIT (SBRA) Mortgage Loans (2019 - 2026)

Sabra Health Care REIT's Mortgage Loans history runs 8 years deep, the most recent figure standing at $432.9 million for Q1 2026.

• In Q1 2026, Mortgage Loans fell 2.53% year-over-year to $432.9 million; the TTM figure through Mar 2026 stood at $432.9 million (down 2.53% YoY), while the FY2025 annual figure was $434.1 million, down 1.92% from the prior year.
• Mortgage Loans was $432.9 million for Q1 2026 at Sabra Health Care REIT, roughly flat from $434.1 million in the prior quarter.
• In the past five years, Mortgage Loans ranged from a high of $444.2 million in Q1 2025 to a low of $390.3 million in Q3 2022.
• Historically, Mortgage Loans has averaged $423.1 million across 5 years, with a median of $422.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Mortgage Loans surged 292.27% in 2022, then slipped 2.53% in 2026.
• A 5-year view of Mortgage Loans shows it stood at $411.4 million in 2022, then climbed by 2.24% to $420.6 million in 2023, then climbed by 5.22% to $442.6 million in 2024, then slipped by 1.92% to $434.1 million in 2025, then dropped by 0.27% to $432.9 million in 2026.
• The last three Mortgage Loans figures came in at $432.9 million (Q1 2026), $434.1 million (Q4 2025), and $436.5 million (Q3 2025), per Business Quant data.